Dr. Tejas P. Deliwala Neurological Care Center Pa - Medicare Mental Health Clinic in Toms River, NJ

Dr. Tejas P. Deliwala Neurological Care Center Pa is a medicare enrolled mental health clinic (Psychiatry & Neurology - Neurology) in Toms River, New Jersey. The current practice location for Dr. Tejas P. Deliwala Neurological Care Center Pa is 3 Plaza Dr, Suite 13, Toms River, New Jersey. For appointments, you can reach them via phone at (732) 240-9222. The mailing address for Dr. Tejas P. Deliwala Neurological Care Center Pa is 3 Plaza Dr Ste 13, Toms River, New Jersey and phone number is (732) 240-9222.

Dr. Tejas P. Deliwala Neurological Care Center Pa is licensed to practice in New Jersey (license number 25MA07557100). The clinic also participates in the medicare program and its NPI number is 1053446062. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (732) 240-9222.

Contact Information

Dr. Tejas P. Deliwala Neurological Care Center Pa
3 Plaza Dr
Suite 13
Toms River
NJ 08757-3759
(732) 240-9222
(732) 240-9221

Mental Health Clinic Profile

Full NameDr. Tejas P. Deliwala Neurological Care Center Pa
SpecialityPsychiatry & Neurology
Location3 Plaza Dr, Toms River, New Jersey
Authorized Official Name and PositionTejas P. Deliwala (PRESIDENT)
Authorized Official Contact7322409222
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr. Tejas P. Deliwala Neurological Care Center Pa
3 Plaza Dr Ste 13
Toms River
NJ 08757-3765

Ph: (732) 240-9222
Dr. Tejas P. Deliwala Neurological Care Center Pa
3 Plaza Dr
Suite 13
Toms River
NJ 08757-3759

Ph: (732) 240-9222

NPI Details:

NPI Number1053446062
Provider Enumeration Date02/22/2007
Last Update Date09/21/2011

Medicare PECOS Information:

Medicare PECOS PAC ID9830281161
Medicare Enrollment IDO20070816000421

News Archive

Secondary prevention program may reduce risks after heart attack

An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.

Integrated care enhances clinical outcomes for dialysis patients

DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for Medicare and Medicaid Services Comprehensive ESRD Care Model as an ESRD Seamless Care Organization.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Dr. Tejas P. Deliwala Neurological Care Center Pa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053446062NPI-NPPES
1585592OtherNJAETNA
4338191OtherNJCIGNA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology 25MA07557100 (New Jersey)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Dr. Tejas P. Deliwala Neurological Care Center Pa acts as a billing entity for following providers:
Provider NameTejas P Deliwala
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1881647188
PECOS PAC ID: 7911983184
Enrollment ID: I20040628001029

News Archive

Secondary prevention program may reduce risks after heart attack

An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.

Integrated care enhances clinical outcomes for dialysis patients

DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for Medicare and Medicaid Services Comprehensive ESRD Care Model as an ESRD Seamless Care Organization.

Read more Medical News

› Verified 4 days ago

News Archive

Secondary prevention program may reduce risks after heart attack

An intensive, comprehensive, long-term secondary prevention program lasting up to three years after cardiac rehabilitation appears to reduce the risk of a second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue of Archives of Internal Medicine , one of the JAMA/Archives journals.

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.

Trial results show routine oral cholera vaccination programme protects people living in endemic regions

An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.

Integrated care enhances clinical outcomes for dialysis patients

DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for Medicare and Medicaid Services Comprehensive ESRD Care Model as an ESRD Seamless Care Organization.

Read more News

› Verified 4 days ago

Psychiatry & Neurology in Toms River, NJ

1198 Medical Associates Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1198 Lakewood Rd Ste 101, Toms River, NJ 08753
Phone: 732-736-6559    
Perfecting Minds Aba Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2265 Hovsons Blvd, Toms River, NJ 08753
Phone: 917-960-0552    
Sea The Light Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 841 Ethan Ct, Toms River, NJ 08753
Phone: 908-910-6000    
Jersey Shore Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 780 Commons Way, Building J, Toms River, NJ 08755
Phone: 732-784-1810    Fax: 732-784-2850
J Smith Life Solutions, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1657 Ferro Lane, Toms River, NJ 08755
Phone: 732-252-7411    
Sarah Tuzeneu Lcsw Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 20 Hadley Ave Ste 3, Toms River, NJ 08753
Phone: 848-251-2462    
Psychological & Behavioral Hlth Ctr George A Peters
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1747 Hooper Ave, Suite 16, Toms River, NJ 08753
Phone: 732-255-3030    Fax: 732-255-5065

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.